This report discusses recent findings on how nicotine metabolism ratios increase among HIV-positive smokers who are on effective antiretroviral therapy. Understanding these changes is crucial for developing targeted smoking cessation strategies for this population.
The study highlights the potential influence of specific ART regimens on nicotine processing, which may affect smoking behaviors and cessation success rates among people living with HIV.